Advertisement
Advertisement
PGNY
Progyny, Inc. Common Stock
17.78
USDSponsored
+0.03
+0.17%
Mar 26, 15:59 UTC -4
Closed
After-Market
17.79
+0.01
+0.05%
PGNY Earnings Reports
Positive Surprise Ratio
PGNY beat 20 of 26 last estimates.
77%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$333.10M
/$0.29
Implied change from Q4 25 (Revenue/ EPS)
+4.62%
/+107.14%
Implied change from Q1 25 (Revenue/ EPS)
+2.80%
/+70.59%
Progyny, Inc. Common Stock earnings per share and revenue
On Feb 26, 2026, PGNY reported earnings of 0.14 USD per share (EPS) for Q4 25, missing the estimate of 0.14 USD, resulting in a -5.34% surprise. Revenue reached 318.40 million, compared to an expected 313.60 million, with a 1.53% difference. The market reacted with a -20.49% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 10 analysts forecast an EPS of 0.29 USD, with revenue projected to reach 333.10 million USD, implying an increase of 107.14% EPS, and increase of 4.62% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
What were Progyny, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Progyny, Inc. Common Stock reported EPS of $0.14, missing estimates by -5.34%, and revenue of $318.40M, 1.53% above expectations.
How did the market react to Progyny, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -20.49%, changed from $22.25 before the earnings release to $17.69 the day after.
When is Progyny, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Progyny, Inc. Common Stock's next earnings report?
Based on 10
analysts, Progyny, Inc. Common Stock is expected to report EPS of $0.29 and revenue of $333.10M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement